Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022. | MMWR Morb Mortal Wkly Rep;71(28): 899-903, 2022 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.

Hause, Anne M; Baggs, James; Marquez, Paige; Abara, Winston E; Baumblatt, Jane Gwira; Thompson, Deborah; Su, John R; Myers, Tanya R; Gee, Julianne; Shimabukuro, Tom T; Shay, David K.

MMWR Morb Mortal Wkly Rep ; 71(28): 899-903, 2022 Jul 15.

Article in En | MEDLINE | ID: mdl-35834416

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Secondary / COVID-19 Vaccines / COVID-19 Limits: Humans Country/Region as subject: America do norte Language: En Journal: MMWR Morb Mortal Wkly Rep Year: 2022 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Secondary / COVID-19 Vaccines / COVID-19 Limits: Humans Country/Region as subject: America do norte Language: En Journal: MMWR Morb Mortal Wkly Rep Year: 2022 Document type: Article Country of publication: